140 related articles for article (PubMed ID: 2419453)
21. Canine lymphoma-associated antigens defined by murine monoclonal antibodies.
Steplewski Z; Jeglum KA; Rosales C; Weintraub N
Cancer Immunol Immunother; 1987; 24(3):197-201. PubMed ID: 3594482
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody defining a Burkitt's lymphoma-associated antigen detects carbohydrate on neutral glycolipid.
Lipinski M; Nudelman ED; Wiels J; Parsons M
J Immunol; 1982 Nov; 129(5):2301-4. PubMed ID: 6181167
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of in vivo tumor growth by a monoclonal IgM antibody recognizing tumor cell surface carbohydrates.
Gil J; Alvarez R; Viñuela JE; Ruiz de Morales JG; Bustos A; De la Concha EG; Subiza JL
Cancer Res; 1990 Nov; 50(22):7301-6. PubMed ID: 2224860
[TBL] [Abstract][Full Text] [Related]
24. A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents.
Lapalombella R; Zhao X; Triantafillou G; Yu B; Jin Y; Lozanski G; Cheney C; Heerema N; Jarjoura D; Lehman A; Lee LJ; Marcucci G; Lee RJ; Caligiuri MA; Muthusamy N; Byrd JC
Clin Cancer Res; 2008 Jan; 14(2):569-78. PubMed ID: 18223233
[TBL] [Abstract][Full Text] [Related]
25. Cloning of a human antibody directed against human neuroblastoma cells and specific for human translation elongation factor 1alpha.
Schilbach K; Kreyenberg H; Geiselhart A; Niethammer D; Handgretinger R
Tissue Antigens; 2004 Feb; 63(2):122-31. PubMed ID: 14705983
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity against L1210 mouse leukemia of immunotoxins containing a monoclonal antibody to the glycolipid globotriaosylceramide.
Junqua S; Wiels J; Tursz T; Le Pecq JB
Immunol Lett; 1987 Jan; 14(2):167-72. PubMed ID: 3495489
[TBL] [Abstract][Full Text] [Related]
27. Predefined gene transfer for expression of a glycosphingolipid antigen by transfection with a cosmid genomic library prepared from a cell line in which the specific glycosphingolipid is highly expressed.
Kojima H; Tsuchiya S; Sekiguchi K; Gelinas R; Hakomori S
Biochem Biophys Res Commun; 1987 Mar; 143(2):716-22. PubMed ID: 3566745
[TBL] [Abstract][Full Text] [Related]
28. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias.
Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T
Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated glycolipid antigens defined by monoclonal antibodies.
Hakomori S
Bull Cancer; 1983; 70(2):118-26. PubMed ID: 6191806
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies that bind to galactosylgloboside (SSEA-3 antigen).
Marcus DM; Gilbert S; Sekine M; Suzuki A
Arch Biochem Biophys; 1988 May; 262(2):620-5. PubMed ID: 3364985
[TBL] [Abstract][Full Text] [Related]
31. Human monoclonal antibody to tumor-associated ganglioside GD2.
Katano M; Saxton RE; Irie RF
J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies and complement purged autograft in Burkitt lymphoma and lymphoblastic leukemia.
Favrot M; Philip I; Combaret V; Pavone E; Bouffet E; Biron P; Philip T
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():202-4. PubMed ID: 2713555
[No Abstract] [Full Text] [Related]
33. Recognition by a natural cytotoxic antibody of lactoneotetraglycosyl ceramide as an antigenic molecule in a syngeneic rat fibrosarcoma.
Takimoto M; Suzuki E; Naiki M; Itaya T; Takeichi N; Hosokawa M; Kobayashi H
Int J Cancer; 1985 Dec; 36(6):695-700. PubMed ID: 2415470
[TBL] [Abstract][Full Text] [Related]
34. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies produced by immunization with neoglycoproteins containing Gal alpha 1-4Gal beta 1-4Glc beta-O and Gal alpha 1-4Gal beta 1-4GlcNAc beta-O residues: useful immunochemical and cytochemical reagents for blood group P antigens and a differentiation marker in Burkitt lymphoma and other B-cell malignancies.
Brodin NT; Dahmén J; Nilsson B; Messeter L; Mårtensson S; Heldrup J; Sjögren HO; Lundblad A
Int J Cancer; 1988 Aug; 42(2):185-94. PubMed ID: 2456994
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth.
Lamon EW; Powell TJ; Walia AS; Lidin BI; Srinivas RV; Baskin JG; Kearney JF
J Natl Cancer Inst; 1987 Mar; 78(3):547-56. PubMed ID: 3469466
[TBL] [Abstract][Full Text] [Related]
37. Coating of liposomes with subunits of monoclonal IgM antibody and targeting of the liposomes.
Hashimoto Y; Sugawara M; Endoh H
J Immunol Methods; 1983 Aug; 62(2):155-62. PubMed ID: 6886428
[TBL] [Abstract][Full Text] [Related]
38. Effect of alemtuzumab on neoplastic B cells.
Golay J; Manganini M; Rambaldi A; Introna M
Haematologica; 2004 Dec; 89(12):1476-83. PubMed ID: 15590398
[TBL] [Abstract][Full Text] [Related]
39. 38.13: a monoclonal antibody directed against a Burkitt's lymphoma-associated antigen and its use as carrier for toxins.
Wiels J; Balaña A; Tursz T
IARC Sci Publ; 1985; (60):457-64. PubMed ID: 4065950
[TBL] [Abstract][Full Text] [Related]
40. Human monoclonal IgM antibodies from foetal B-cell hybridomas directed against a surface antigen on human tumour cells.
Bohn J; Josimovic-Alasevic O; Settmacher U; Kiessig ST; Lukowsky A; Volk HD; Diamantstein T; Von Baehr R; Jahn S
Res Immunol; 1992; 143(9):879-91. PubMed ID: 1289988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
